Add Company
Join Now

PROTA THERAPEUTICS PTY LTD Revenue and Competitors

License our Company Data API

Melbourne, au

Location

N/A

Total Funding

Research Services

Industry

Employee Data

  • PROTA THERAPEUTICS PTY LTD has 5 Employees.(i)
  • PROTA THERAPEUTICS PTY LTD grew their employee count by 25% last year.

PROTA THERAPEUTICS PTY LTD's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A8219%N/AN/A
#2
N/A2125%N/AN/A
#3
N/A6831%N/AN/A
#4
N/A7220%N/AN/A
#5
N/A40%N/AN/A
#6
N/A8584%N/AN/A
#7
N/A6120%N/AN/A
#8
N/A5249%N/AN/A
#9
N/A6324%N/AN/A
#10
N/A9027%N/AN/A
Add Company

What Is PROTA THERAPEUTICS PTY LTD?

Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel combination probiotic allergen oral immunotherapy treatments. Prota holds an exclusive license to the patented probiotic food immunotherapy technology, developed at the MCRI. Series A funding of AUD $15m was secured from OneVentures, a leading Australian venture capital investment firm (OneVentures' Healthcare Fund III) – including $5M from the Australian Commonwealth Government Biomedical Translation Fund – as well as private investment. This has enabled Prota to advance their clinical program, develop scalable cGMP product manufacturing processes, and initiate discussions with regulatory agencies in the lead up to a planned large-scale pivotal Phase 3 efficacy and safety study for the PRT100 peanut allergy treatment.

keywords:N/A

N/A

Total Funding

5

Number of Employees

N/A

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M5-37%N/A
#2
$0.4M567%N/A
#3
$0.4M50%N/A
#4
$0.4M50%N/A
#5
$0.3M5-17%N/A